{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:11:07Z","timestamp":1791670267412,"version":"4.3.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":306,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"UK Dermatology Clinical Trials Network","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/bjd.13163","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T15:29:40Z","timestamp":1401982180000},"page":"1422-1427","source":"Crossref","is-referenced-by-count":54,"title":["The Hidradenitis Suppurativa Priority Setting Partnership"],"prefix":"10.1093","volume":"171","author":[{"given":"J.R.","family":"Ingram","sequence":"first","affiliation":[{"name":"Department of Dermatology & Wound Healing; Institute of Infection & Immunity; Heath Park Cardiff CF14 4XW U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Abbott","sequence":"additional","affiliation":[{"name":"Cardiff & Vale University Health Board; University Hospital of Wales; Heath Park Cardiff CF14 4XW U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ghazavi","sequence":"additional","affiliation":[{"name":"Nottingham NHS Treatment Centre; Queen's Medical Campus; Lister Road Nottingham NG7 2FT U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Alexandroff","sequence":"additional","affiliation":[{"name":"University Hospitals of Leicester NHS Trust; Infirmary Square Leicester LE1 5WW U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"McPhee","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology; King's Meadow Campus; University of Nottingham; Lenton Lane Nottingham NG7 2NR U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Burton","sequence":"additional","affiliation":[{"name":"The Hidradenitis Suppurativa Trust; PO Box 550 Chatham ME4 9AH U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Clarke","sequence":"additional","affiliation":[{"name":"James Lind Alliance; Summertown Pavilion Middle Way Oxford OX2 7LG U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,30]]},"reference":[{"key":"10.1111\/bjd.13163-BIB0001|bjd13163-cit-0001","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13163-BIB0002|bjd13163-cit-0002","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13163-BIB0003|bjd13163-cit-0003","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2133.2010.09715.x","article-title":"Interobserver variability of clinical scores in hidradenitis suppurativa is low","volume":"162","author":"Sartorius","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13163-BIB0004|bjd13163-cit-0004","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13163-BIB0005|bjd13163-cit-0005","first-page":"530","article-title":"Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership","volume":"164","author":"Eleftheriadou","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13163-BIB0006|bjd13163-cit-0006","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/bjd.12040","article-title":"The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of eczema","volume":"168","author":"Batchelor","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13163-BIB0007|bjd13163-cit-0007","unstructured":"James Lind Alliance The James Lind Alliance Guidebook http:\/\/www.jlaguidebook.org"},{"key":"10.1111\/bjd.13163-BIB0008|bjd13163-cit-0008","unstructured":"National Institute for Health and Care Excellence U.K. Database of Uncertainties about the Effects of Treatment (DUETs) http:\/\/www.library.nhs.uk\/duets"},{"key":"10.1111\/bjd.13163-BIB0009|bjd13163-cit-0009","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2340\/00015555-0747","article-title":"Treatment of hidradenitis suppurativa with tumour necrosis factor-\u03b1 inhibitors","volume":"89","author":"Haslund","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.13163-BIB0010|bjd13163-cit-0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.det.2010.03.012","article-title":"Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review","volume":"28","author":"Shuja","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.13163-BIB0011|bjd13163-cit-0011","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archdermatol.2011.1950","article-title":"A systematic review of treatments for hidradenitis suppurativa","volume":"148","author":"Rambhatla","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13163-BIB0012|bjd13163-cit-0012","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/09546634.2012.674193","article-title":"The off-label treatment of severe hidradenitis suppurativa with TNF-\u03b1 inhibitors: a systematic review","volume":"24","author":"Rappard","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.13163-BIB0013|bjd13163-cit-0013","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/11631880-000000000-00000","article-title":"Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?","volume":"13","author":"Alhusayen","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.13163-BIB0014|bjd13163-cit-0014","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.12104","article-title":"Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review","volume":"168","author":"Blok","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13163-BIB0015|bjd13163-cit-0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaad.2013.04.032","article-title":"Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases","volume":"69","author":"Machet","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 5","key":"10.1111\/bjd.13163-BIB0016|bjd13163-cit-0016","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1610-0387.2012.08006.x","article-title":"S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa * (number ICD-10 L73.2)","volume":"10","author":"Zouboulis","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.13163-BIB0017|bjd13163-cit-0017","first-page":"235","article-title":"A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa","volume":"65","author":"Morgan","year":"1983","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1111\/bjd.13163-BIB0018|bjd13163-cit-0018","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00042728-200802000-00012","article-title":"Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study","volume":"34","author":"Buimer","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.13163-BIB0019|bjd13163-cit-0019","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13163","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13163\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:10:26Z","timestamp":1676383826000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/171\/6\/1422\/6616286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,30]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13163","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,30]]}}}